CVRX
CVRx IncNASDAQHEALTHCAREMEDICAL DEVICES
Key Statistics
Market Cap
$196.81M
P/E Ratio
—
EPS
$-2.04
Beta
1.12
52W High
$11.30
52W Low
$4.30
50-Day MA
$7.55
200-Day MA
$7.93
Dividend Yield
—
Profit Margin
-94.10%
Forward P/E
—
PEG Ratio
—
About CVRx Inc
CVRx, Inc. develops implantable technology for the treatment of patients with high blood pressure / hypertension and heart failure.
Fundamentals
| Revenue (TTM) | $56.65M |
| Gross Profit (TTM) | $48.34M |
| EBITDA | $-50.51M |
| Operating Margin | -69.80% |
| Return on Equity | -96.60% |
| Return on Assets | -26.90% |
| Revenue/Share (TTM) | $2.17 |
| Book Value | $1.50 |
| Price-to-Book | 6.03 |
| Price-to-Sales (TTM) | 3.47 |
| EV/Revenue | 3.74 |
| EV/EBITDA | -1.31 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 4.40% |
| Shares Outstanding | $26.31M |
| Float | $18.16M |
| % Insiders | 9.35% |
| % Institutions | 66.15% |
Historical Volatility
HV 10-Day
87.03%
HV 20-Day
72.45%
HV 30-Day
67.35%
HV 60-Day
98.04%
HV Rank
—
Volatility is currently expanding
Analyst Ratings
Consensus ($11.17 target)
1
Strong Buy5
Buy1
Strong SellData last updated: 4/10/2026